Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection

Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis

(2021) Milo Gatti et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Antibiotic treatment adequacy and death among patients with Pseudomonas aeruginosa airway infection

(2020) Josefin Eklöf et al.   PLoS One

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

(2020) Mohd H. Abdul-Aziz et al.   INTENSIVE CARE MEDICINE

Therapeutic drug monitoring of anti-infective agents in critically ill patients

(2016) Nynke G. L. Jager et al.   Expert Review of Clinical Pharmacology

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

An international, multicentre survey of  -lactam antibiotic therapeutic drug monitoring practice in intensive care units

(2014) G. Wong et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome

(2014) Raquel Cavalcanti Dantas et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients

(2014) Kevin S. Akers et al.   Journal of Trauma and Acute Care Surgery

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic

(2012) Jason A Roberts et al.   BMC INFECTIOUS DISEASES

Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin

(2012) Isabelle K. Delattre et al.   CLINICAL BIOCHEMISTRY

Clinical Characteristics and Risk Factors for Mortality in Patients with Bacteremia Caused by Pseudomonas aeruginosa

(2012) Tetsuya Horino et al.   INTERNAL MEDICINE

Augmented renal clearance in septic patients and implications for vancomycin optimisation

(2012) João Pedro Baptista et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units*

(2011) David S. Y. Ong et al.   CRITICAL CARE MEDICINE

Augmented Renal Clearance

(2009) Andrew A. Udy et al.   CLINICAL PHARMACOKINETICS

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS